|
|
|
|
| LEADER |
00000csc a2200000 a 4500 |
| 001 |
24959-3 |
| 005 |
20230308214327.0 |
| 008 |
996062|1995 ||||||||r|||||||||||spa|| |
| 020 |
|
|
|a 9682521718
|
| 040 |
|
|
|b spa
|
| 041 |
1 |
|
|a spa
|
| 082 |
0 |
|
|a 618.9
|
| 245 |
|
|
|a Resistencia a antimicrobianos
|c John R. Schreiber y Donald A. Goldman directores; José Rafael Blengio traductor
|h imp
|n 3/6
|
| 264 |
|
|
|a México
|b Interamericana
|c 1995
|
| 300 |
|
|
|a XIV, pp 463-692
|b ilu
|
| 300 |
|
|
|c 22x16 cm
|
| 310 |
|
|
|a Bimestral
|
| 490 |
|
|
|a Clínicas Pediátricas de Norteamérica
|v volumen 3/6
|
| 504 |
|
|
|a incl. ref.
|
| 650 |
1 |
|
|a Resistencia bacteriana
|9 93297
|
| 650 |
|
|
|a Bacterias resistentes
|9 297290
|
| 650 |
|
|
|a Otitis
|9 160299
|
| 650 |
|
|
|a Neumococos
|9 297291
|
| 650 |
|
|
|a Antibióticos
|9 34302
|
| 650 |
|
|
|a Estreptococos
|9 71142
|
| 650 |
|
|
|a Tuberculosis farmacoresistentes
|9 297292
|
| 650 |
|
|
|a Antivirales
|9 111974
|
| 650 |
|
|
|a Enterococos
|9 297293
|
| 650 |
|
|
|a Vancomicina
|9 297294
|
| 650 |
|
|
|a Estafilococos
|9 72140
|
| 650 |
|
|
|a Paludismo
|9 18844
|
| 650 |
|
|
|a Antimicóticos
|9 85831
|
| 700 |
|
|
|a Schreiber, John R
|e director
|9 297295
|
| 700 |
|
|
|a Goldmann, Donald A
|e director
|9 297296
|
| 700 |
|
|
|a Blengio, José Rafaél
|e traductor
|9 269433
|
| 773 |
|
|
|t Resistencia a antimicrobianos
|
| 852 |
|
|
|a UC-SALUD
|c ESTANTERIA ABIERTA
|f Compra
|k mariana.feican
|l 1
|m General
|p 19960620/20130423
|q S/. 106.900
|t 24959-3
|b 0
|d CDRS
|e CDRS
|g 618.9 ESTANTERIA ABIERTA
|z 1996-60-62
|
| 942 |
|
|
|
| 999 |
|
|
|c 128405
|d 128405
|